In glioblastoma patients, copy number loss of the genes encoding the ATM/Chk2 and ATR/Chk1 pathways frequently occurs, with heterozygous loss of CHEK2 being the most common occurrence. The gene discussed is CHEK2; the disease is glioblastoma.